Kenneth B Roberts MD

Professor of Therapeutic Radiology; Medical Director, Yale-New Haven Shoreline Medical Center, Department of Radiation Oncology; Associate Chief and Medical Director for Radiation Oncology at Shoreline Medical Center, Yale-New Haven Hospital

Specialties & Subspecialties

Gamma Knife Center, Yale-New Haven

Cancer Center, Yale: Brain Tumor Center | Gastrointestinal Cancer Program | Gynecologic Oncology Program | Pediatric Hematology & Oncology Program | Hematology Program

Therapeutic Radiology

Education & Training

  • B.S., Massachusetts Institute of Technology (1979)
  • M.D., Duke University (1984)
  • MAST OTHER, Duke University School of Law (1994)
  • Resident, Duke University Medical Center , Radiation Oncology (1989 - 1992)
  • Resident, Ohio State University Hospitals , Internal Medicine (1984 - 1987)
  • Fellow, Duke University Medical Center , Hematology-Oncology (1987 - 1989)

Patient Care

Accepts New Patients? Yes | Patient Type: Adult, Child | Accepts referrals from patients


Clinical Interests

General radiation therapy; pediatric radiation therapy; hematologic malignancy; lymphoma; Hodgkin’s disease; total body irradiation; endovascular brachytherapy; oncologic brachytherapy; gynecologic cancer; cervix cancer; gastrointestinal cancer; colorectal cancer


Cancers Treated

Bone, Bone Marrow Transplant & Stem Cell Support, Brachytherapy, Brain, Cervix, Chest Wall Tumors, Colon (including Rectum), Esophagus, Gastrointestinal (including Stomach), Genitourinary, Hematologic Disorders (except Leukemia), Hodgkin's Disease, Leukemia, Lymphoma (Non-Hodgkin's), Pancreas, Pediatric, Prostate, Sarcoma


Board Certifications

  • Internal Medicine, Board Certified (1987)
  • Radiation Oncology, Board Certified (1995)
  • Medical Oncology, Board Certified (1989)

Clinical Trials

ConditionsStudy Title
Chordoma, Desmoid Tumor, Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma, and Soft TissueA COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol (COG 9902)
Graft Versus Host Disease, Myelodysplastic Syndromes, Leukemia, not otherwise specified, and Non-Hodgkin's LymphomaA Multicenter, Phase II Study of Selective Depletion of CD45RA+ T Cells from Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD
Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia, and Lymphoid LeukemiaTreatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (AALL0932) (CIRB)
Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma, and Brain and Nervous SystemANBL0032: PHASE III RANDOMIZED STUDY OF CHIMERIC ANTIBODY 14.18 (Ch14.18) IN HIGH RISK NEUROBLASTOMA FOLLOWING MYELOABLATIVE THERAPY AND AUTOLOGOUS STEM CELL RESCUE

Edit Profile